Determinants of Non-Disclosure to Sexual Partner among Human immune virus Infected Adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa Zone public Hospitals in Oromia Region, Ethiopia, 2020.

BackgroundHIV positive status non-disclosure to sexual partner remains challenging for the prevention and control of Human Immune Virus infection as it results in poor antiretroviral treatment adherence, high risk of transmission and limits women’s ability in the prevention of mother to child transmission. ObjectiveThe study tried to identify determinants of non-disclosure to sexual partner/s among Human immune virus infected Adult on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. MethodsA hospital based unmake case control study was conducted from December 1 to February 30/2020 among 378 (94 cases and 284 controls) Human immune virus infected adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. Epi data version 3.1 for data entry and SPSS version 25 for analysis were used. To find factors significantly associated with non-disclosure to sexual partner/s, Bivariable and Multivariable logistic regression analysis were done. ResultOf a total of 378 sampled study respondents, 369 were interviewed (92 cases and 277 controls) giving response rate of 97.5%. Among the study participants 39.3% (36 cases and 109 controls) were in the age group of 31-40 years and more than half of the respondents, 53.4% (61 cases and 136 controls) were females. Regarding educational and marital status, 39.3% (100 controls and 45 cases) were unable to read and write and 69.6% (211 controls and 46 cases) were married. Variables that showed significant association with non-disclosure to sexual partner were male sex (AOR: 0.25, 95% CI: 0.13-0.47), ART duration <36 months (AOR:2.13, 95% CI: 1.14-4.01), Being on WHO clinical staging one (AOR: 3.00, 95% CI: 1.26-7.12), Having more than one lifetime sexual partner (AOR: 0.46, 95% CI: 0.22-0.95) and not seeing person/s publically disclosed HIV status (AOR: 3.12, 95% CI: 1.47-6.65). ConclusionsThis study endorsed that promoting public HIV disclosure and having one sexual partner helps disclosure to sexual partner/s. Deep and continuous HIV disclosure counseling service is needed for Female, for those being in WHO clinical staging one and ART duration <36 months.

Impact of attitudes and beliefs on antiretroviral treatment adherence intention among HIV-positive pregnant and breastfeeding women in Zambia

Objective The aim of this study was to investigate if attitudes or behavioral beliefs about antiretroviral therapy (ART) influence ART adherence intention among pregnant and breastfeeding women in Zambia. Methods We recruited 150 HIV-positive women receiving ART in urban (Lusaka) and rural (Sinazongwe) districts of Zambia. Generalized modified Poisson regression models were used to assess the extent to which adherence intention was influenced by attitude toward ART or behavioral beliefs about ART. Results Intention to adhere to ART differed significantly by income, knowledge about HIV transmission, attitudes, and behavioral beliefs (all Ps < .05). In addition, strong intention to adhere to ART differed by urban (69%) and rural (31%) place of residence (P ≤ .01). In adjusted models, women in the weak adherence intention group were more likely to be older, have less knowledge about HIV transmission, and have a more negative attitude toward ART (PR 0.74; 95% CI 0.67–0.82). Behavioral belief about ART, however, was significant in unadjusted model (PR 0.85; 95% CI 0.76–0.94) but not significant after adjusting for covariates such as age, knowledge of transmission, and district locality. Conclusion Compared to behavioral beliefs, attitudes about ART were more influential for intention to adhere. This knowledge will help inform effective and appropriate ART counseling for pregnant and breastfeeding women at different points along their ART time course.